[#item_full_content] Drug Enforcement Administration (DEA) is opposing marijuana rescheduling opponents’ request to reopen an ongoing hearing on the Trump administration’s proposed reform for a new round of testimony and document discovery. The dispute concerns a recently released federal watchdog report that found there are “gaps” in the government’s process for evaluating controlled substances. DEA said in
Read More